PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Treatment for juvenile offenders shows shows positive results 22 years later

Treatment for juvenile offenders shows shows positive results 22 years later
2011-11-21
(Press-News.org) COLUMBIA, Mo. – More than 20 years ago, Charles Borduin, a University of Missouri researcher, developed a treatment for juvenile offenders that has become one of the most widely used evidence-based treatments in the world. Now, he has found that the treatment continues to have positive effects on former participants more than 20 years after treatment.

Throughout the course of his career, Borduin, professor of psychological sciences in the College of Arts & Science, has pioneered the treatment called Multisystemic Therapy (MST) as a way to prevent serious mental health problems in children and adolescents. MST interventions involve the offender's entire family and community, as opposed to the more common individual therapy, where the offender visits a therapist who offers feedback, support and encouragement for behavior change.

Borduin followed up with clinical trial participants that completed treatment nearly 22 years earlier, on average. He found the following differences between participants who received MST and those who received individualized therapy: Violent felonies: Since completing treatment, 4.3 percent of juveniles treated with MST were arrested for a violent felony, compared to 15.5 percent of individual therapy participants. All felonies: Overall, 34.8 percent of MST participants committed a felony, compared to 54.8 percent of individual therapy participants. Misdemeanors: MST participants committed five times fewer misdemeanors than individual therapy participants. Family problems: Individual therapy participants were involved in family-related civil suits two times more often than MST participants.

"This research shows that Multisystemic Therapy has long-lasting effects," said Borduin. "Nearly 22 years after treatment, juvenile offenders treated with MST still see positive effects. This treatment has protected many potential victims, and I hope this research helps to encourage further use of the method."

MST is used in 12 countries around the world, as well as in 34 states. In Norway, it is the national model for juvenile offender treatment. Borduin said MST is the most widely used evidence-based treatment for juvenile offenders in the U.S.; however, only 1 to 2 percent of juvenile offenders receive the treatment.

The study follows an original clinical trial that took place between 1983 and 1986. In the original trial, the 176 children who participated in the study were randomly selected for treatment with MST or individual therapy. For this study, Borduin located records for more than 80 percent of participants. On average, the follow-up occurred 21.9 years following the conclusion of treatment. Borduin said this is one of the longest post-treatment period follow-ups ever done for a psychological evidence-based treatment of any disorder.

In a previous study, Borduin found that the net cumulative benefit of providing MST to a single juvenile offender resulted in a savings to taxpayers and crime victims of $75,110 to $199,374 over nearly 14 years. Borduin now plans to study savings over the course of almost 22 years following treatment.

Borduin's findings were recently published in the Journal of Consulting and Clinical Psychology. He collaborated with Aaron Sawyer, a graduate student in the Department of Psychological Sciences.

INFORMATION:

[Attachments] See images for this press release:
Treatment for juvenile offenders shows shows positive results 22 years later

ELSE PRESS RELEASES FROM THIS DATE:

One for you, one for me

One for you, one for me
2011-11-21
KANSAS CITY, MO -- Each time a cell divides -- and it takes millions of cell divisions to create a fully grown human body from a single fertilized cell -- its chromosomes have to be accurately divvied up between both daughter cells. Researchers at the Stowers Institute for Medical Research used, ironically enough, the single-celled organism Saccharomyces cerevisiae -- commonly known as baker's yeast -- to gain new insight into the process by which chromosomes are physically segregated during cell division. In a study published in the Nov. 17, 2011 issue of PLoS Genetics, ...

Somoto Toolbar Was Recently Released By The Company

2011-11-21
The Somoto toolbar was recently released by the company. It is considered as one of their solutions for monetization. The Somoto toolbar have been provided to the community of freeware programmers and software program. They are making preparations for total expansion by using launches of contemporary product and additional partners joining the membership of the network. Somoto was founded by Eyal Yaakov and Ben Garrun. They recognized that programmers had a necessity for improved software, amplified revenues and increased distribution functionality. The two founders have ...

First Attorney Social Bookmarking Site Launched by Legal Web Experts

First Attorney Social Bookmarking Site Launched by Legal Web Experts
2011-11-21
Attorney website design and marketing agency Legal Web Experts is announcing the launch of http://www.mylegalbookmarks.com , the first social bookmarking website for lawyers and legal professionals. The site allows users to share news, websites, internet resources and other law-related web content with individuals in the legal profession as well as people with similar interests. "The legal industry is so large and has so much information available online that it deserves a social bookmarking website dedicated to it specifically," says Ryan Nelson, Director ...

'Trans-parency' in the workplace

2011-11-21
Transsexual individuals who identify themselves as such in the workplace are more likely to have greater satisfaction and commitment to their job than transsexuals who do not, according to a new study from Rice University and Pennsylvania State University. "Trans-parency in the Workplace: How the Experiences of Transsexual Employees Can Be Improved" will appear in an upcoming issue of the Journal of Vocational Behavior. For the study, researchers surveyed 88 transsexuals across the nation about their workplace experiences to determine what factors impact their job satisfaction ...

Study identifies 'silent' stroke risk factors for children with sickle cell anemia

2011-11-21
WASHINGTON, November 17, 2011 -- Factors such as low hemoglobin levels, increased systolic blood pressure, and male gender are linked to a higher risk of silent cerebral infarcts (SCIs), or silent strokes, in children with sickle cell anemia (SCA), according to results from a large, first-of-its-kind study published online today in Blood, the Journal of the American Society of Hematology (ASH). Silent strokes are the most common form of neurological injury found in SCA, with more than 25 percent of children with the disorder suffering a SCI by age six,1 and nearly 40 ...

Squid mystery in Mexican waters unraveled by Stanford biologist and a class of students

Squid mystery in Mexican waters unraveled by Stanford biologist and a class of students
2011-11-21
While shorter days and colder weather move many of us to hunker under the covers, researchers who spent their summers in fieldwork are more likely to be hunched over microscopes and curled over keyboards, scrutinizing samples and crunching data from their summer's labors. One such researcher is marine biologist William Gilly, who spent a month last summer in Mexico's Sea of Cortez tracking the sometimes-elusive Humboldt squid. Researchers from several universities were on the voyage. Gilly is in the second year of a quest to understand the surprisingly strong impact ...

Separating signal and noise in climate warming

2011-11-21
LIVERMORE, Calif. -- In order to separate human-caused global warming from the "noise" of purely natural climate fluctuations, temperature records must be at least 17 years long, according to climate scientists. To address criticism of the reliability of thermometer records of surface warming, Lawrence Livermore National Laboratory scientists analyzed satellite measurements of the temperature of the lower troposphere (the region of the atmosphere from the surface to roughly five miles above) and saw a clear signal of human-induced warming of the planet. Satellite measurements ...

In an enzyme critical for life, X-ray emission cracks mystery atom

2011-11-21
ITHACA, N.Y. - Like a shadowy character just hidden from view, a mystery atom in the middle of a complex enzyme called nitrogenase had long hindered scientists' ability to study the enzyme fully. But now an international team of scientists led by Serena DeBeer, Cornell assistant professor of chemistry and chemical biology, has pulled back the curtain using powerful synchrotron spectroscopy and computational modeling to reveal carbon as the once-elusive atom. The research was published online Nov. 17 in the journal Science. "For chemists, one of the first steps you ...

Environmental conditions and predators affect Atlantic salmon survival in the Gulf of Maine

2011-11-21
Stocks of Atlantic salmon (Salmo salar), which have been steadily declining for the past few decades, are facing new challenges in the Gulf of Maine, where changing spring wind patterns, warming sea surface temperatures and new predators along altered migration routes are affecting their survival. In a paper published online in the journal Fisheries Management and Ecology, Kevin Friedland and co-authors suggest post-smolts are entering an increasingly warmer coastal ocean, where they are facing mortality risks associated with a changing climate, such as changing distributions ...

Researchers discover new way to form extracellular vesicles

2011-11-21
Researchers at NYU Langone Medical Center have discovered a protein called TAT-5 that affects the production of extracellular vesicles, small sacs of membrane released from the surface of cells, capable of sending signals to other cells. When released extracellular vesicles can affect tumor spread, blood clotting and inflammation. Their discovery gives new insight into how extracellular vesicles form, and reveals new potential strategies to manipulate diseases such as cancer. The study was published online November 17, 2011 in Current Biology. "Very little is known ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Treatment for juvenile offenders shows shows positive results 22 years later